Document is current
Any future updates will be listed below
-
Authors
Singh, Shakti
Barbarino, Ashley
Youssef, Eman G.
Das Gupta, Kaustav
Nabeela, Sunna
Gebremariam, Teclegiorgis
Alkhazraji, Sondus
Uppuluri, Priya
Ostroff, Garry
Ibrahim, Ashraf S.
-
Funding
Funding for this research was provided by:
National Center for Advancing Translational Sciences (KL2TR001882)
American Heart Association (938451)
National Institute of Allergy and Infectious Diseases (1R01AI141202)
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 7 May 2026
First Online: 16 May 2026
Competing interests
: A.S.I. is the founder of Vitalex Biosciences, which is developing novel antifungal immunotherapies. S.S., T.G., S.A., and P.U. own shares in Vitalex Biosciences. All other co-authors do not have competing interests.
